Concepedia

Author

Donald L. Bussolotti

Pfizer (United States)

Also Known As

D. L. BUSSOLOTTI, Donald Bussolotti, Donald L. Bussolotti

16

Publications

237

Citations

7

H-Index

22

Concepts

All Affiliations

Pfizer (United States)
DL

About

Donald L. Bussolotti is an author at Pfizer (United States) specializing in medicine, pharmacology, and medicinal chemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

145

2

Biochemistry

3

3

121

3

Natural Sciences

2

2

98

4

Engineering

1

1

24

5

Health Sciences

1

1

23

Donald L. Bussolotti

×

6

Publications

224

Citations

6

H-Index

YearCitations

Analogs of S-adenosylhomocysteine as potential inhibitors of biological transmethylation. Inhibition of several methylases by S-tubercidinylhomocysteine

James K. Coward, Donald L. Bussolotti, Chi‐Deu Chang

Journal of Medicinal Chemistry

1974

50

Stable multisubstrate adducts as enzyme inhibitors

John S. Heller, E.S. Canellakis, Donald L. Bussolotti,

Biochimica et Biophysica Acta (BBA) - Enzymology

1975

48

Hydantoin bioisosteres. In vivo active spiro hydroxy acetic acid aldose reductase inhibitors

Christopher A. Lipinski, Charles E. Aldinger, Thomas A. Beyer,

Journal of Medicinal Chemistry

1992

40

Synthesis and evaluation of some stable multisubstrate adducts as inhibitors of catechol O-methyltransferase

Gary L. Anderson, Donald L. Bussolotti, James K. Coward

Journal of Medicinal Chemistry

1981

39

Synthesis of 11.alpha.,9.alpha.-epoxymethanothromboxane A2: a stable, optically active TxA2 agonist

Thomas Schaaf, Donald L. Bussolotti, M. J. PARRY,

Journal of the American Chemical Society

1981

24

Glucose Transport-Enhancing and Hypoglycemic Activity of 2-Methyl-2-phenoxy-3-phenylpropanoic Acids

Reinhard Sarges, Richard F. Hank, James F. Blake,

Journal of Medicinal Chemistry

1996

23

Page 1